NanoPharm's Unattributed - III Round

NanoPharm raised a round of funding on October 14, 2015.

NanoPharm, dba HylaPharm, has a novel drug-delivery technology that makes treatment of certain types of cancer, including breast cancer and head and neck cancer, both safer and more effective. Using t…

Articles about NanoPharm's Unattributed - III Round: